The effects of low bone mineral density on pain, quality of life and fatigue in patients with epilepsy

Year 2021, , 286 - 291, 27.10.2021

Cagri Unal-ulutatar Gonca Yazıcı Sacaklıdır Ipek Mıdı Gulseren Derya Akyuz

https://doi.org/10.5472/marumj.1009016

Abstract

Objectives: To investigate the effects of low bone mineral density (BMD) on pain, quality of life (QoL), and fatigue in epileptic patients
who use anticonvulsants.
Patients and Methods: Epileptic patients aged 18 years or older who use anticonvulsant drugs were recruited into the study.
Demographic and clinical features were recorded, including the duration of epilepsy, number of anticonvulsants used, previous
fracture history and BMD scores. The functional parameters included back pain measured with the visual analogue scale (VAS) and
brief pain inventory (BPI) scale, QoL assessed with the Qualeffo-41 questionnaire, and fatigue assessed with the fatigue severity scale
(FSS).
Results: Of the 100 patients screened for inclusion in the study, 63 epileptic patients met the inclusion criteria. The mean age and
mean disease duration of all participants was 39.5 (±11.2) and 19.3 (±11.6) years, respectively. The median scores for VAS back pain,
VAS low back pain, Qualeffo-41, FSS, pain severity, and pain interference (BPI) were significantly higher in patients with secondary
osteoporosis compared to patients with normal BMD. There were significant correlations between lumbar spinal BMD and VAS
back pain (rho = – 0.58, p < 0.0005), BPI pain severity (rho = – 0.56, p < 0.0005), BPI pain interference (rho = – 0.52, p < 0.0005),
Qualeffo-41 (rho = – 0.56, p < 0.0005), and FSS (rho = – 0.41, p = 0.001).
Conclusion: Epileptic patients suffering from low BMD showed increased pain, fatigue and impaired QoL. Therefore, BMD
measurement should be recommended for the evaluation and management of epileptic patients.

Keywords

Epilepsy, Quality of life, Bone mineral density, Fatigue, Pain

References

• [1] Martin R, Vogtle L, Gilliam F, Faught E. What are the concerns of older adults living with epilepsy? Epilepsy Behav 2005; 7:297-300. doi: 10.1016/j.yebeh.2005.05.003.
• [2] Elliott JO, Seals BF, Jacobson MP. Use of the Precaution Adoption Process Model to examine predictors of osteoprotective behavior in epilepsy. Seizure 2007;16:424-37. doi: 10.1016/j.seizure.2007.02.016. Epub 2007 Apr 18.
• [3] Tedrus GMAS, Sterca GS, Pereira RB. Physical activity, stigma, and quality of life in patients with epilepsy. Epilepsy Behav 2017;77:96-8. doi: 10.1016/j.yebeh.2017.07.039. Epub 2017 Oct 12.
• [4] Drezner MK. Treatment of anticonvulsant drug-induced bone disease. Epilepsy Behav 2004;5:41-7. doi: 10.1016/j. yebeh.2003.11.028.
• [5] Özemir ZA, Yalçın AD. Antiepileptik ilaçların kemik yoğunluğuna ve metabolizmasına etkileri. Epilepsi 2017;23:1- 6. doi:10.14744/epilepsi.2016.93723.
• [6] Christiansen C, Rødbro P, Lund M. Incidence of anticonvulsant osteomalacia and effect of vitamin D: controlled therapeutic trial. Br Med J 1973;4(5894):695-701. doi: 10.1136/ bmj.4.5894.695.
• [7] Albayrak I, Aydogmus M, Ozerbil OM, Levendoglu F. The association between bone mineral density, quality of life, quality of sleep and fatigue. Acta Clin Belg 2016;71:92-8. doi: 10.1179/229.533.3715Y.000.000.0061. Epub 2016 Feb 8.
• [8] Wilson S, Sharp C, Davie M. Health-related quality of life in patients with osteoporosis in the absence of vertebral fracture: a systematic review. Osteoporos Int 2012;23:2749-68. doi: 10.1007/s00198.012.2050-6.
• [9] Vestergaard P. Epilepsy, osteoporosis and fracture risk–a meta‐analysis. Acta Neurol Scand 2005;112:277-86. doi: 10.1111/j.1600-0404.2005.00474.x.
• [10] Cranney A, Jamal SA, Tsang JF, Josse RG, Leslie WD. Low bone mineral density and fracture burden in postmenopausal women. CMAJ 2007;177:575-80. doi: 10.1503/cmaj.070234.
• [11] Kanis JA, McCloskey EV, Johansson H, Oden A, Melton III LJ, Khaltaev N. A reference standard for the description of osteoporosis. Bone 2008;42:467-75. doi: 10.1016/j. bone.2007.11.001. Epub 2007 Nov 17.
• [12] Catalano A, Martino G, Morabito N, Scarcella C, Gaudio A, Basile G, et al. Pain in osteoporosis: from pathophysiology to therapeutic approach. Drugs Aging 2017;34:755-65. doi: 10.1007/s40266.017.0492-4.
• [13] Mirza F, Canalis E. Secondary osteoporosis: pathophysiology and management. Eur J Endocrinol 2015;173(3):R131-R51. doi: 10.1530/EJE-15-0118
• [14] Densitometry ISfC. Diagnosis of osteoporosis in men, premenopausal women, and children. J Clin Densitom 2004;7(1):17-26. doi: 10.1385/jcd:7:1:17 [published Online First: 2004/01/27]
• [15] Huskisson EC. Measurement of pain. The lancet 1974;304(7889):1127-31. doi: 10.1016/s0140-6736(74)90884- 8.
• [16] Cleeland CS. The brief pain inventory: user guide. Houston, TX: The University of Texas MD Anderson Cancer Center 2009:1-11.
• [17] Dicle A, Karayurt Ö, Dirimese E. Validation of the Turkish version of the Brief Pain Inventory in surgery patients. Pain Manag Nurs 2009;10(2):107-13. e2. doi: 10.1016/j. pmn.2008.08.002.
• [18] Lips P, Cooper C, Agnusdei D, Caulin F, Egger P, Johnell O, et al. Quality of life as outcome in the treatment of osteoporosis: the development of a questionnaire for quality of life by the European Foundation for Osteoporosis. Osteoporos Int 1997;7:36-8. doi: 10.1007/bf01623457 [published Online First: 1997/01/01].
• [19] Kocyigit H, Gülseren Ş, Erol A, Hizli N, Memis A. The reliability and validity of the Turkish version of Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Clin Rheumatol 2003;22:18-23. doi: 10.1007/ s10067.002.0653-6.
• [20] Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989;46(:1121-23. doi: 10.1001/archneur.1989.005.20460115022.
• [21] Cohen RJ, Swerdlik ME, Phillips SM. Psychological testing and assessment: An introduction to tests and measurement. California:Mayfield Publishing Co, 1996.
• [22] Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, NJ: Erlbaum, 1988.
• [23] Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007;39:175-91. doi: 10.3758/bf03193146. [published Online First: 2007/08/19].
• [24] Mazziotti G, Canalis E, Giustina A. Drug-induced osteoporosis: mechanisms and clinical implications. Am J Med 2010;123:877-84. doi: 10.1016/j.amjmed.2010.02.028 [published Online First: 2010/10/06].
• [25] Farhat G, Yamout B, Mikati MA, Demirjian S, Sawaya R, El- Hajj Fuleihan G. Effect of antiepileptic drugs on bone density in ambulatory patients. Neurology 2002;58:1348-53. doi: 10.1212/wnl.58.9.1348 [published Online First: 2002/05/16].
• [26] Chin WW. The partial least squares approach to structural equation modeling. In: Marcoulides GA, ed. Modern methods for business research. New York: Psychology Press, 1998:295- 336.
• [27] Berto P. Quality of life in patients with epilepsy and impact of treatments. Pharmacoeconomics 2002;20:1039-59. doi: 10.2165/00019.053.200220150-00002.
• [28] Sahin-Onat S, Unsal Delialioglu S, Bicer S, Ozel S. Effects of Sleep Quality on Quality of Life in patients with osteoporosis. Turkish Journal of Osteoporosis 2013;19:32-7. [29] Kwon O-Y, Ahn HS, Kim HJ. Fatigue in epilepsy: A systematic review and meta-analysis. Seizure 2017;45:151-59. doi: 10.1016/j.seizure.2016.11.006.
• [30] Kubota F, Kifune A, Shibata N, et al. Bone mineral density of epileptic patients on long-term antiepileptic drug therapy: a quantitative digital radiography study. Epilepsy Res 1999;33:93-7. doi: 10.1016/s0920-1211(98)00077-1 [published Online First: 1999/03/27].
• [31] Stephen LJ, McLellan AR, Harrison JH, et al. Bone density and antiepileptic drugs: a case-controlled study. Seizure 1999;8:339-42. doi: 10.1053/seiz.1999.0301 [published Online First: 1999/10/08].
• [32] Ravn P, Cizza G, Bjarnason N, Thompson D, et al. Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. J Bone Miner Res 1999;14:1622-27. doi: 10.1359/jbmr.1999.14.9.1622.
• [33] Korpelainen R, Korpelainen J, Heikkinen J, Väänänen K, Keinänen-Kiukaanniemi S. Lifelong risk factors for osteoporosis and fractures in elderly women with low body mass index-a population-based study. Bone 2006;39:385-91. doi: 10.1016/j.bone.2006.01.143. Epub 2006 Mar 10.